Compare Revvity Inc (RVTY) vs Valaris Limited Common Shares (VAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Valaris Limited Common Shares — how do they compare? Revvity Inc trades at $155 (market cap $16.97B), while Valaris Limited Common Shares trades at $84.6 (market cap $5.88B). The key difference: Revvity Inc is far larger — about 2.9× Valaris Limited Common Shares's market cap, and Revvity Inc pays a 0.18% dividend while Valaris Limited Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 13 Days and Valaris Limited Common Shares for 0 Days on average.
| RVTY | VAL | |
|---|---|---|
Market Cap | $16.97B | $5.88B |
Volume | 1,602,713 | 1,857,693 |
Sector | Health | Energy |
52-Week High | $157.36 | $113.42 |
52-Week Low | $82.26 | $48.15 |
Typical Hold Time | 13 Days | 0 Days |
Enterprise Value | $19.29B | $6.51B |
Dividend Yield | 0.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $155.08, down 0.34% today but near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving average support. Recent earnings beats and a Zacks upgrade to Buy reflect positive momentum. The company launched a new Type 1 diabetes screening kit in Europe and announced the acquisition of Human Cell Design, expanding its metabolic disease research tools.
Outlook remains positive with revenue stability and margin pressures manageable. Investment opportunity lies in diagnostic growth and AI-driven demand, though premium valuation and China market risks warrant caution. The absence of sell ratings and strong institutional accumulation support a constructive view, but rich multiples require sustained earnings delivery for further upside.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Valaris Limited Common Shares
Valaris Limited provides offshore contract drilling services to the oil and gas industry, operating a fleet of drillships, semisubmersibles, and jackup rigs across multiple regions worldwide.
Read more on VAL →
